Company: HURA
Filing Date: 2025-09-18
Form Type: S-1/A
Source: 0001193125-25-207395
Chunk: 172

Company: TuHURA Biosciences, Inc./NV
Filing Date: 2025-09-18
Form: S-1/A
Chunk 172
---
 The TuHURA Common Warrants have an exercise price of $5.70 per share of our common stock and have an expiration date of three years following the respective issue dates of the warrants. The TuHURA Common Warrants are exercisable at any time prior to the expiration date of the warrants, and the warrants are exercisable for cash and, at such time as there is no registration statement covering the resale of the shares issuable upon the exercise of the warrants, on a cashless basis. The TuHURA Common Warrants contain customary adjustments to the exercise price and number of underlying warrant shares by reason of stock splits, stock dividends, reverse stock split, and the like.

<div align='center'>110</div>

In connection with the TuHURA Note Financing, an aggregate of approximately 0.1 million shares of our common stock (calculated on a post-Kintara Merger basis) were issued to a placement agent for the private placement of the TuHURA Note Financing. Private Placement of Common Stock by Legacy TuHURA In July 2024, approximately 0.7 million shares of our common stock (calculated on a post-Kintara Merger basis) were issued and sold in a private offering by Legacy TuHURA with a purchase price of $5.0 million to an existing stockholder. Cash Flows The following table sets forth a summary of the net cash flow activity for the years ended December 31, 2024 and 2023, respectively:

|                                 |     | Year Ended December 31, 
 2024                    |             |   |     | 2023 |             |   |
|:--------------------------------|:----|:------------------------|------------:|:--|:----|:-----|------------:|:--|
| Net cash provided by (used in): |     |                         |             |   |     |      |             |   |
| Operating activities            |     | $                       | (14,728,138 | ) |     | $    | (11,950,856 | ) |
| Investing activities            |     |                         |  (6,052,409 | ) |     |      |  (1,296,879 | ) |
| Financing activities            |     |                         |  29,772,693 |   |     |      |   2,660,249 |   |
| Net increase (decrease) in cash |     | $                       |   8,992,146